NEXTHERA CAPITAL LP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 134 filers reported holding CARA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.5%.

Quarter-by-quarter ownership
NEXTHERA CAPITAL LP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$17,658,000
+111.6%
737,303
+69.2%
3.38%
+161.9%
Q2 2018$8,346,000
+92.0%
435,800
+24.1%
1.29%
+80.4%
Q1 2018$4,346,000
+93.9%
351,050
+141.1%
0.72%
-26.6%
Q2 2017$2,241,000
-37.5%
145,600
-25.3%
0.98%
-46.7%
Q1 2017$3,586,000
+54.4%
195,000
-22.0%
1.83%
+34.4%
Q4 2016$2,323,000250,0001.36%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders